SCHEMBL26857089

SCHEMBL26857089

Cn1ccc(CNC(=O)c2cc(-c3ccc4nc(N)nn4c3)cs2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.39
▸ PIK3CG P48736 6/20 0.39
▸ PIK3CD O00329 6/20 0.39
▸ PIK3CA P42336 4/20 0.39
▸ PIK3CB P42338 2/20 0.39
▸ HPGDS O60760 1/20 0.38
▸ MARK3 P27448 3/20 0.37
▸ MMP12 P39900 2/20 0.37
▸ TTK P33981 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ SLC40A1 Q9NP59 1/20 0.36
▸ SGK1 O00141 1/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ MAPK13 O15264 1/20 0.35
▸ PDPK1 O15530 1/20 0.35
▸ NUAK1 O60285 1/20 0.35
▸ CCNT1 O60563 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ CHEK2 O96017 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26857109 0.86 MARK3 (0.41) MAPK1PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL26857092 0.86 TTK (0.40) MAPK1PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL26857023 0.86 PIK3CG (0.41) PIK3CGPIK3CDPIK3CAPIK3CBMMP12
SCHEMBL26857094 0.85 MARK3 (0.44) MAPK1PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL26857161 0.85 ADORA3 (0.42) PIK3CGPIK3CDPIK3CAPIK3CBMARK3
SCHEMBL26857148 0.85 MARK3 (0.46) PIK3CGPIK3CDPIK3CAPIK3CBMARK3
SCHEMBL26857087 0.84 MARK3 (0.38) MAPK1PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL26856882 0.83 MMP12 (0.53) MAPK1PIK3CGPIK3CDPIK3CBMMP12
SCHEMBL26857115 0.83 KMT2A (0.43) MAPK1MMP12
SCHEMBL26857084 0.83 PIK3CG (0.39) PIK3CGPIK3CDPIK3CAPIK3CBMMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF SNCA, PSEN2, PARK7 MAPK1 3172/4885PIK3CG 690/4885PIK3CD 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback